Suchergebnisse - "Immunologic Factors"

PubPharm (1.438)

1

Novel immunomodulatory therapies in myasthenia gravis

enthalten in: Revue medicale suisse | 2024

von Sukockiené, E. | Théaudin, M. | Loser, V. | +3

2

Multiple myeloma, haematologic malignancy and immunosuppressant and immunomodulatory medications are associated with sebaceous carcinoma, a pharmacovigilance study of the FDA adverse event reporting system

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Jedlowski, P. | DuPont, J.

3

Substantial and comparable suppression of disease activity following early initiation of cladribine tablets, ocrelizumab or alemtuzumab as first pharmacologic treatment for relapsing multiple sclerosis : A real world study

enthalten in: Clinical neurology and neurosurgery | 2024

von Alroughani, R. | Al-Hashel, J. | Ahmed, S.

4

Small-molecule modulators of tumor immune microenvironment

enthalten in: Bioorganic chemistry | 2024

von Zhang, J. | Yu, J. | Liu, M. | +7

5

Risk of Cancer Recurrence in Patients With Immune-Mediated Diseases With Use of Immunosuppressive Therapies : An Updated Systematic Review and Meta-Analysis

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2024

von Gupta, A. | Peyrin-Biroulet, L. | Ananthakrishnan, A.

6

Potential factors associated with a long-term duration of B-cell depletion after using rituximab in patients with nephrotic syndrome

enthalten in: Pediatric nephrology (Berlin, Germany) | 2024

von Xue, C. | Dai, B.

7

Ocrelizumab in highly disabled progressive multiple sclerosis patients

enthalten in: Multiple sclerosis and related disorders | 2024

von Houtchens, M. | Howard, D.

8

Changes in adverse events after multiple rituximab courses in patients with complicated steroid-dependent nephrotic syndrome

enthalten in: Clinical and experimental nephrology | 2024

von Morishita, T. | Fujinaga, S.

9

Clinical trial : Combination allopurinol-thiopurine versus standard thiopurine in patients with IBD escalating to immunomodulators (the DECIDER study)

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Vasudevan, A. | Con, D. | De Cruz, P. | +6

10

Withdrawal of Immunomodulators or TNF Antagonists in Patients With Inflammatory Bowel Diseases in Remission on Combination Therapy : A Systematic Review and Meta-analysis

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2024

von Katibian, D. | Solitano, V. | Polk, D. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[144]